Understanding the Different Glyphosate Safety Conclusions

The International Agency for Research on Cancer (IARC), a part of the World Health Organization, plays a critical role in evaluating potential carcinogens. In its 2015 report, the IARC classified glyphosate as "probably carcinogenic to humans." This classification raises important questions about glyphosate regulation and safety.

The Difference Between Hazard and Risk

To comprehend the implications of IARC's conclusion, it is vital to understand the difference between hazard and risk. IARC assesses whether a substance is a hazard, meaning it has the potential to cause cancer, rather than the actual risk it poses to individuals. For example, smoking can cause cancer, but if a person does not smoke or is not exposed to secondhand smoke, their risk remains negligible.

Regulatory Perspectives: IARC vs. EFSA

The IARC's evaluation differs from that of the European Food Safety Authority (EFSA), which provides risk assessments that inform European policies. The IARC's assessment is often regarded as more rigorous, relying solely on publicly available, peer-reviewed data, while EFSA incorporates proprietary information from the industry, which may not be accessible to the broader scientific community.

Scientific Divergences

Differences in scientific conclusions often arise from varying sets of evidence, methodological approaches, or interpretations of ambiguous results. Additionally, the regulatory process can be compromised by issues such as conflicts of interest among regulators and reliance on unpublished industry data, potentially overshadowing independent scientific research.

The Evidence on Glyphosate and Cancer

IARC identified a "limited evidence in humans" linking glyphosate exposure to non-Hodgkin lymphoma. In contrast, EFSA's experts deemed the evidence as "very limited" and insufficient to warrant a classification. Despite the limited human data, IARC considered animal studies and strong evidence of genotoxicity and oxidative stress sufficient to support its classification.

Glyphosate Regulation and Use

As glyphosate's re-registration was evaluated in the European Union in 2018, both hazard-based and risk-based analyses were considered. While IARC’s assessments provide critical insights, they may not yield practical significance in regulatory contexts. Ultimately, the U.S. Environmental Protection Agency and EFSA concluded that glyphosate is unlikely to cause cancer, increasing its Acceptable Daily Intake value within the EU from 0.3 to 0.5 mg/kg of body weight. In the U.S., the Acceptable Daily Intake is approximately three times higher at 1.75 mg/kg body weight. In 2023, the European Commission reapproved glyphosate for another decade.

The Scale of Glyphosate Use

Glyphosate-based herbicides represent the most commonly used herbicide class globally, with significant usage in U.S. agriculture. Approximately 93% of the U.S. soy crop and 85% of the corn crop are treated with glyphosate. This translates to over 250 million pounds (113,400 metric tons) applied annually in the U.S. alone, impacting various crops including wheat, cotton, fruits, and vegetables. In Europe, glyphosate is applied to up to 50% of crops such as olives, grapes, and apples.

The Vicious Cycle of Glyphosate Use

As glyphosate use increases, so does the development of glyphosate-resistant weeds, leading to a cycle of escalating herbicide use. Farmers are applying greater quantities of glyphosate more frequently throughout the year, including new applications such as pre-harvest desiccation to hasten crop harvesting. However, the long-term effects of this heightened glyphosate usage remain uncertain.

Conclusion

The debate surrounding glyphosate safety highlights the complexities of hazard versus risk assessments and the influence of regulatory practices. As the use of glyphosate continues to rise, understanding its implications for health and the environment becomes ever more critical.